Merck & Co.
Venture Capital
MRL Ventures Fund partners with founders on breakthrough therapeutics, investing globally in early-stage preclinical companies with Merck expertise.
Early Stage
Growth
- Headquarters
- Cambridge, United States
- Founded
- 2014
- Website
- merck.com
- AUM
- $500.0M
- Last Investment
- Nov 2025
Investment Thesis
Invest in first-in-class therapeutics across modalities from seed stage, providing sustained capital, board support, and scientific guidance for patient impact.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account